RhumbLine Advisers Portfolio holdings
AUM
$117B
This Quarter Return
-14.6%
1 Year Return
+24.59%
3 Year Return
+106.81%
5 Year Return
+195.15%
10 Year Return
+469.64%
AUM
$68.5B
AUM Growth
+$68.5B
(-12%)
Cap. Flow
+$5.25B
Cap. Flow
% of AUM
7.67%
Top 10 Holdings %
Top 10 Hldgs %
21.45%
Holding
3,376
New
361
Increased
2,433
Reduced
286
Closed
283
Top Buys
| 1 |
Amazon
AMZN
|
$1.52B |
| 2 |
Linde
LIN
|
$114M |
| 3 |
Apple
AAPL
|
$99.4M |
| 4 |
Microsoft
MSFT
|
$98.6M |
| 5 |
Warner Bros
WBD
|
$53.9M |
Top Sells
| 1 |
CERN
Cerner Corp
CERN
|
$50.9M |
| 2 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
$30.4M |
| 3 |
NXP Semiconductors
NXPI
|
$26.8M |
| 4 |
Yum China
YUMC
|
$18.8M |
| 5 |
PBCT
People's United Financial Inc
PBCT
|
$14.8M |
Sector Composition
| 1 | Technology | 23.14% |
| 2 | Healthcare | 14.42% |
| 3 | Financials | 13.45% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Passage Bio
PASG
$22.7M
| – | – | -46,558 | Closed | -$144K |
|
3352
PAVmed
PAVM
$10.6M
| – | – | -64,615 | Closed | -$85K |
|
3353
Puma Biotechnology
PBYI
$254M
| – | – | -38,775 | Closed | -$112K |
|
3354
Park-Ohio Holdings
PKOH
$291M
| – | – | -11,653 | Closed | -$164K |
|
3355
Pliant Therapeutics
PLRX
$101M
| – | – | -22,867 | Closed | -$160K |
|
3356
Pulse Biosciences
PLSE
$1.05B
| – | – | -13,340 | Closed | -$65K |
|
|
PPTA
3357
Perpetua Resources
PPTA
$2.03B
| – | – | -16,811 | Closed | -$69K |
|
3358
Prelude Therapeutics
PRLD
$68.5M
| – | – | -10,050 | Closed | -$69K |
|
3359
Personalis
PSNL
$434M
| – | – | -44,975 | Closed | -$368K |
|
3360
Quantum Corp
QMCO
$99M
| – | – | -70,670 | Closed | -$160K |
|
3361
Quince Therapeutics
QNCX
$85.9M
| – | – | -19,411 | Closed | -$120K |
|
3362
Avita Medical
RCEL
$117M
| – | – | -22,913 | Closed | -$194K |
|
3363
Rekor Systems
REKR
$141M
| – | – | -34,677 | Closed | -$158K |
|